BCI Marketplace
Depression Neuromodulation trials

External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

RecruitingNCT06788977Phase: Not specifiedStarted 2024-11-25

Summary

This online registry aims to understand the potential benefits and safety of external trigeminal nerve stimulation for the treatment of migraine in pregnant women. Women do not need to use external trigeminal nerve stimulation or any other form of migraine treatment to participate in the registry. The main question it aims to answer is: Is external trigeminal nerve stimulation a safe and effective option for migraine treatment during and after pregnancy? There are no required changes in migra

Eligibility

Sex
FEMALE
Min Age
18 Years
Max Age
44 Years

Inclusion Criteria: 1. Patients willing and able to provide simple consent for registry participation. 2. Has access to email, text messages via smartphone or computer with internet access 3. Be between the ages of 18 to 44 years at enrollment. 4. Pregnant with one fetus/baby at time of enrollment

Locations

https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceLanguage=true
Darien, Connecticut, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →